Global Sickle Cell Market Research Report 2023

The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some factors which can hinder growth of the market including regulatory changes, associated risks and slow adoption of treatments.

The global Sickle Cell market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. is expected to be the first region to start the selling of sickle cell drugs due to developing drug therapies and later on, market penetration of sickle cell drugs would occur in Europe.

This report aims to provide a comprehensive presentation of the global market for Sickle Cell, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sickle Cell.

The Sickle Cell market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Sickle Cell market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sickle Cell companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sickle Cell Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Diagnosis

1.2.3 Treatment

1.3 Market by Application

1.3.1 Global Sickle Cell Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Sickle Cell Market Perspective (2018-2029)

2.2 Sickle Cell Growth Trends by Region

2.2.1 Global Sickle Cell Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Sickle Cell Historic Market Size by Region (2018-2023)

2.2.3 Sickle Cell Forecasted Market Size by Region (2024-2029)

2.3 Sickle Cell Market Dynamics

2.3.1 Sickle Cell Industry Trends

2.3.2 Sickle Cell Market Drivers

2.3.3 Sickle Cell Market Challenges

2.3.4 Sickle Cell Market Restraints

3.1 Global Top Sickle Cell Players by Revenue

3.1.1 Global Top Sickle Cell Players by Revenue (2018-2023)

3.1.2 Global Sickle Cell Revenue Market Share by Players (2018-2023)

3.2 Global Sickle Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sickle Cell Revenue

3.4 Global Sickle Cell Market Concentration Ratio

3.4.1 Global Sickle Cell Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Revenue in 2022

3.5 Sickle Cell Key Players Head office and Area Served

3.6 Key Players Sickle Cell Product Solution and Service

3.7 Date of Enter into Sickle Cell Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Sickle Cell Historic Market Size by Type (2018-2023)

4.2 Global Sickle Cell Forecasted Market Size by Type (2024-2029)

5.1 Global Sickle Cell Historic Market Size by Application (2018-2023)

5.2 Global Sickle Cell Forecasted Market Size by Application (2024-2029)

6.1 North America Sickle Cell Market Size (2018-2029)

6.2 North America Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Sickle Cell Market Size by Country (2018-2023)

6.4 North America Sickle Cell Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Sickle Cell Market Size (2018-2029)

7.2 Europe Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Sickle Cell Market Size by Country (2018-2023)

7.4 Europe Sickle Cell Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Sickle Cell Market Size (2018-2029)

8.2 Asia-Pacific Sickle Cell Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Sickle Cell Market Size by Region (2018-2023)

8.4 Asia-Pacific Sickle Cell Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Sickle Cell Market Size (2018-2029)

9.2 Latin America Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Sickle Cell Market Size by Country (2018-2023)

9.4 Latin America Sickle Cell Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Sickle Cell Market Size (2018-2029)

10.2 Middle East & Africa Sickle Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Sickle Cell Market Size by Country (2018-2023)

10.4 Middle East & Africa Sickle Cell Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Sickle Cell Introduction

11.1.4 Novartis Revenue in Sickle Cell Business (2018-2023)

11.1.5 Novartis Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Detail

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Sickle Cell Introduction

11.2.4 Bristol-Myers Squibb Revenue in Sickle Cell Business (2018-2023)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Takeda

11.3.1 Takeda Company Detail

11.3.2 Takeda Business Overview

11.3.3 Takeda Sickle Cell Introduction

11.3.4 Takeda Revenue in Sickle Cell Business (2018-2023)

11.3.5 Takeda Recent Development

11.4 Bluebird Bio

11.4.1 Bluebird Bio Company Detail

11.4.2 Bluebird Bio Business Overview

11.4.3 Bluebird Bio Sickle Cell Introduction

11.4.4 Bluebird Bio Revenue in Sickle Cell Business (2018-2023)

11.4.5 Bluebird Bio Recent Development

11.5 Global Blood Therapeutics

11.5.1 Global Blood Therapeutics Company Detail

11.5.2 Global Blood Therapeutics Business Overview

11.5.3 Global Blood Therapeutics Sickle Cell Introduction

11.5.4 Global Blood Therapeutics Revenue in Sickle Cell Business (2018-2023)

11.5.5 Global Blood Therapeutics Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Sickle Cell Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Diagnosis

    Table 3. Key Players of Treatment

    Table 4. Global Sickle Cell Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Sickle Cell Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Sickle Cell Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Sickle Cell Market Share by Region (2018-2023)

    Table 8. Global Sickle Cell Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Sickle Cell Market Share by Region (2024-2029)

    Table 10. Sickle Cell Market Trends

    Table 11. Sickle Cell Market Drivers

    Table 12. Sickle Cell Market Challenges

    Table 13. Sickle Cell Market Restraints

    Table 14. Global Sickle Cell Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Sickle Cell Market Share by Players (2018-2023)

    Table 16. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell as of 2022)

    Table 17. Ranking of Global Top Sickle Cell Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Sickle Cell Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Sickle Cell Product Solution and Service

    Table 21. Date of Enter into Sickle Cell Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Sickle Cell Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Sickle Cell Revenue Market Share by Type (2018-2023)

    Table 25. Global Sickle Cell Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Sickle Cell Revenue Market Share by Type (2024-2029)

    Table 27. Global Sickle Cell Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Sickle Cell Revenue Market Share by Application (2018-2023)

    Table 29. Global Sickle Cell Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Sickle Cell Revenue Market Share by Application (2024-2029)

    Table 31. North America Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Sickle Cell Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Sickle Cell Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Sickle Cell Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Sickle Cell Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Sickle Cell Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Sickle Cell Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Sickle Cell Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Sickle Cell Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Sickle Cell Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Sickle Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Sickle Cell Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Sickle Cell Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Novartis Company Detail

    Table 47. Novartis Business Overview

    Table 48. Novartis Sickle Cell Product

    Table 49. Novartis Revenue in Sickle Cell Business (2018-2023) & (US$ Million)

    Table 50. Novartis Recent Development

    Table 51. Bristol-Myers Squibb Company Detail

    Table 52. Bristol-Myers Squibb Business Overview

    Table 53. Bristol-Myers Squibb Sickle Cell Product

    Table 54. Bristol-Myers Squibb Revenue in Sickle Cell Business (2018-2023) & (US$ Million)

    Table 55. Bristol-Myers Squibb Recent Development

    Table 56. Takeda Company Detail

    Table 57. Takeda Business Overview

    Table 58. Takeda Sickle Cell Product

    Table 59. Takeda Revenue in Sickle Cell Business (2018-2023) & (US$ Million)

    Table 60. Takeda Recent Development

    Table 61. Bluebird Bio Company Detail

    Table 62. Bluebird Bio Business Overview

    Table 63. Bluebird Bio Sickle Cell Product

    Table 64. Bluebird Bio Revenue in Sickle Cell Business (2018-2023) & (US$ Million)

    Table 65. Bluebird Bio Recent Development

    Table 66. Global Blood Therapeutics Company Detail

    Table 67. Global Blood Therapeutics Business Overview

    Table 68. Global Blood Therapeutics Sickle Cell Product

    Table 69. Global Blood Therapeutics Revenue in Sickle Cell Business (2018-2023) & (US$ Million)

    Table 70. Global Blood Therapeutics Recent Development

    Table 71. Research Programs/Design for This Report

    Table 72. Key Data Information from Secondary Sources

    Table 73. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Sickle Cell Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Sickle Cell Market Share by Type: 2022 VS 2029

    Figure 3. Diagnosis Features

    Figure 4. Treatment Features

    Figure 5. Global Sickle Cell Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Sickle Cell Market Share by Application: 2022 VS 2029

    Figure 7. Hospitals Case Studies

    Figure 8. Clinics Case Studies

    Figure 9. Ambulatory Surgical Centers Case Studies

    Figure 10. Sickle Cell Report Years Considered

    Figure 11. Global Sickle Cell Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 12. Global Sickle Cell Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 13. Global Sickle Cell Market Share by Region: 2022 VS 2029

    Figure 14. Global Sickle Cell Market Share by Players in 2022

    Figure 15. Global Top Sickle Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sickle Cell as of 2022)

    Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Revenue in 2022

    Figure 17. North America Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 18. North America Sickle Cell Market Share by Country (2018-2029)

    Figure 19. United States Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. Canada Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Europe Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Sickle Cell Market Share by Country (2018-2029)

    Figure 23. Germany Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. France Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. U.K. Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Italy Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Russia Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Nordic Countries Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Asia-Pacific Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Sickle Cell Market Share by Region (2018-2029)

    Figure 31. China Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Japan Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. South Korea Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Southeast Asia Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. India Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Australia Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Latin America Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Sickle Cell Market Share by Country (2018-2029)

    Figure 39. Mexico Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Brazil Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Middle East & Africa Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Sickle Cell Market Share by Country (2018-2029)

    Figure 43. Turkey Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Saudi Arabia Sickle Cell Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Novartis Revenue Growth Rate in Sickle Cell Business (2018-2023)

    Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Business (2018-2023)

    Figure 47. Takeda Revenue Growth Rate in Sickle Cell Business (2018-2023)

    Figure 48. Bluebird Bio Revenue Growth Rate in Sickle Cell Business (2018-2023)

    Figure 49. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Business (2018-2023)

    Figure 50. Bottom-up and Top-down Approaches for This Report

    Figure 51. Data Triangulation

    Figure 52. Key Executives Interviewed